Recent Updates
Recently added Catalysts
MRKR

and agree with the statements made by TapImmune regarding my resignations Sincerely, /s/ Denis Corin Denis Corin President, Acting Chief Financial Officer and Acting Principal Accounting Officer

Key Takeaway: This will serve as my resignation from the Board of Directors of TapImmune Inc. ("TapImmune") and from any position as an officer (including as President, Acting Chief Financial Officer and Acting Principal Accounting Officer) or employee of TapImmune Inc. These resignations do n

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+35%
120-day peak, hindsight
Typical move
5.1%
average across 5 past catalysts
Cash runway
~9 mo
Medium dilution risk
Lead asset
Low dose FRα vaccine
Phase 2 · Breast Cancer

Full Press Release Details

This will serve as my resignation from the Board of Directors of TapImmune Inc. ("TapImmune") and from any position as an officer (including as President, Acting Chief Financial Officer and Acting Principal Accounting Officer) or employee of TapImmune Inc. These resignations do not include the resignation from a consultancy arrangement that I am entering into with TapImmune Inc. simultaneously with my resignations. These resignations do not arise from, or are the result of, any disagreements with TapImmune, TapImmune's independent accountants, TapImmune's counsel or with TapImmune's operations, policies or practices.
I have read TapImmune's Current Report on Form 8-K describing my resignation (to which this letter will be attached as Exhibit 99.1) and agree with the statements made by TapImmune regarding my resignations
Last updated: May 14, 2012